Allergan rejects Valeant and Ackman’s raised takeover offer

(Reuters) – The battle for botox maker Allergan Inc heated up on Tuesday as the company officially rejected a sweetened $53 billion takeover offer from Valeant Pharmaceuticals International and activist investor William Ackman.



Link to article: feeds.reuters.com/~r/reuters/businessNews/~3/P1vwzUW79Rg/story01.htm

Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *